Putnam Investments LLC Fibrogen Inc Transaction History

Putnam Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.49 - $20.59 $7,216 - $59,669	-2,898 Reduced 3.04%	92,361 $249,000
Q1 2023 May 22, 2023	SELL	$15.95 - $25.18 $322,429 - $509,013	-20,215 Reduced 17.51%	95,259 $1.78 Million
Q4 2022 Feb 14, 2023	SELL	$13.27 - $17.73 $875 - $1,170	-66 Reduced 0.06%	115,474 $1.85 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $23,940 - $30,660	-2,100 Reduced 1.79%	115,540 $1.5 Million
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $11,592 - $18,921	-1,460 Reduced 1.23%	117,640 $1.24 Million
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $60,364 - $84,319	-5,022 Reduced 4.05%	119,100 $1.43 Million
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $1.23 Million - $1.91 Million	124,122 New	124,122 $1.75 Million
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $2.42 Million - $3.2 Million	-65,271 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $2.64 Million - $2.97 Million	65,271 New	65,271 $2.68 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.